Tissue Fluorescence Spectroscopy Lecture 16. Outline Steady-state fluorescence –Instrumentation and Data Analysis Methods Statistical methods: Principal.

Slides:



Advertisements
Similar presentations
Endometrial polyps Dr Shaun Monagle MBBS 1991.
Advertisements

HPV Testing and Genotyping
Clinical Use of HPV DNA Testing Thomas C. Wright, Jr. College of Physicians and Surgeons of Columbia University.
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Module 6 “Normal Values”: How are Normal Reference Ranges Established?
Lecture 17 Tissue fluorescence (Part II). Dimension reduction: Principal Component Analysis Component loadings spectra 337 nm 380 nm 460 nm.
Lecture 10. The time-dependent transport equation Spatial photon gradient Photons scattered to direction ŝ' Absorbed photons Photons scattered into direction.
Introduction Women experience distress and heightened anxiety in relation to further diagnostic evaluation of pre-cancerous cell changes of the cervix,
Lecture 25 Review. Medical Optics and Lasers Application of optical methods to medicine Why optical methods? –Non-invasive –No side-effects –High resolution.
Evolution of Neoplasia The Uterine Cervix As a Model Raj C. Dash, MD Duke University Medical Center Durham, North Carolina.
ASHLYN SAVAGE, MD, MSCR ASSOCIATE PROFESSOR OBSTETRICS AND GYNECOLOGY MEDICAL UNIVERSITY OF SOUTH CAROLINA Managing Abnormal Pap Smears: Incorporating.
Comparison of HPV Testing and Spectroscopy Combined with Cytology for the Detection of High- grade Cervical Neoplasia C Werner, W Griffith III, R Ashfaq,D.
Classification of Microarray Data. Sample Preparation Hybridization Array design Probe design Question Experimental Design Buy Chip/Array Statistical.
Cervical Cancer Cervical dysplasia Cervical cancer Causes Risk factors
CALIBRATION Prof.Dr.Cevdet Demir
Classification of Microarray Data. Sample Preparation Hybridization Array design Probe design Question Experimental Design Buy Chip/Array Statistical.
Feature Screening Concept: A greedy feature selection method. Rank features and discard those whose ranking criterions are below the threshold. Problem:
ENHANCING DETECTION.... YOUR PRACTICE.
HPV and cervical screening Test of cure
Screening for Cervical Cancer
Benign and premalignant disease of the cervix
Cervical Cancer: Prevention and Treatment
Module 4: Screening and Diagnosis. Diagnosis Definitive diagnosis of oral cancer must be confirmed by scalpel biopsy and histological assessment Without.
PRE-INVASIVE DISEASE OF THE CERVIX CERVICAL INTRAEPHELIAL NEOPLASIA DR. AMEL AL-SAYED Asst. Prof. & Consultant Ob/Gyne Dept.
Thoughts on Biomarker Discovery and Validation Karla Ballman, Ph.D. Division of Biostatistics October 29, 2007.
Cytopathology: Technique and Interpretation
CERVICAL SCREENING WITH LUVIVA MACHINE FOR EARLY DETECTION OF CERVICAL DYSPLASIA: EXPERIENCE FROM EKITI STATE, NIGERIA Sunday O. Omoya, Abimbola M. Obimakinde.
Screening Tests for Brest & Cervical Cancer
Diaddddddd122223d Diagnosis of esophagial cancer (Artesh medical university) Dr Saidi.
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
Screening for Cervical Cancer by Visual Inspection Techniques Dr Aruna Batra VMMC & SJH.
Early methods of diagnostic in oral medicine
STUDY OF MULTIMODAL HYPERSPECTROSCOPY IN A POPULATION OF WOMEN AT RISK FOR CERVICAL CANCER Olutosin Awolude α, Brenda Shultz β, Babatunde Akinwunmi α,
Cancer of Cervix Shashi. Sep-15 Introduction: Best example of cancer prevention. Best example of cancer prevention. Potentially curable if detected early.
SoftPAP® A Novel Collection Device for Cervical Cytology.
Screening for cervical cancer. Screening for cervical lesions Common disease Cancer is preventable Screening is easy MUST BE PERFORMED.
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Screening.
Introductory Statistics for Laboratorians dealing with High Throughput Data sets Centers for Disease Control.
Cervical Intraepithelial Neoplasm
Cancer of Cervix Shashi. Oct-15 Introduction: Best example of cancer prevention. Best example of cancer prevention. US Statistics: US Statistics: Leading.
Spectroscopy Mahsa Ranji ECE-E641.
Michal Tepper Under the supervision of Prof. Israel Gannot.
Cytologic and DNA- Cytometric Early Diagnosis of Oral Cancer Torsten W. Remmerbach, Horst Weidenbach, Natalja Pomjanski, Kristiane Knops, Stefanie Mathes,
 Cervical cancer kills about women a year.  It’s the commonest cause of death from cancer in women.it’s the commonest after breast cancer. 
1 WIDE-FIELD AND HIGH-RESOLUTION OPTICAL IMAGING FOR EARLY DETECTION OF ORAL NEOPLASIA Professor: WANG,CHI-JO Student: CHEN,CHING-YUAN 1 Proc. of SPIE.
Premalignant lesions of the cervix. Applied anatomy.
Screening of genital cancers Evidence Based Presented by Dr\ Heba Nour.
3D Face Recognition Using Range Images Literature Survey Joonsoo Lee 3/10/05.
COLPOSCOPY QUESTIONS Michael R. Downs M.D. October 2004.
Dr. Ahmed jasim Ass.Prof.MBChB-DOG-FICMS COSULTANT OF GYN. & OBST. COSULTANT OF GYN. & OBST.
Cytopathology Feb
Date of download: 6/27/2016 Copyright © 2016 SPIE. All rights reserved. Sample CP-A and CP-B cells labeled with fluorescent protoporphyrin IX (PpIX) in.
Using the Fisher kernel method to detect remote protein homologies Tommi Jaakkola, Mark Diekhams, David Haussler ISMB’ 99 Talk by O, Jangmin (2001/01/16)
Cervical Cancer Screening NURS 541: Women’s Healthcare – Diagnosis and Management.
Date of download: 9/18/2016 Copyright © 2016 SPIE. All rights reserved. Schematic diagram of the spectroscopy module attached to the endoscopy imaging.
Cancer prevention and early detection
CERVIX.
Precancerous diseases of red border of lips and oral mucous membrane
INTRODUCTION: CERVICAL CANCER SCREENING
Haishan Zeng, Annette McWilliams, Stephen Lam, MD, FRCPC 
FISH of urothelial cells
The Accuracy of Diagnostic Colposcopy Using ISCCP 2011 Classification
INTERNATIONAL CONFERENCE SURGERY ACCESS IN TROPICAL AREAS AND UPDATES IN ONCOLOGY THE VALUE OF AUTOFLUORESCENCE BRONCHOSCOPY FOR THE DETECTION OF EARLY.
Using Laser Raman Spectroscopy to Reduce False Positives of Autofluorescence Bronchoscopies: A Pilot Study  Michael A. Short, PhD, Stephen Lam, MD, Annette.
Breast Imaging Ravi Adhikary, MD.
SH-sheikhhasani Gyn-oncologist
A and B, images from a patient with an invasive carcinoma on the floor of the mouth. A and B, images from a patient with an invasive carcinoma on the floor.
Evidence Based Diagnosis
Scatter plots of the posterior probability values belonging to normal and IM gastric tissue categories calculated by (A) FP; (B) HW; and (C) integrated.
Presentation transcript:

Tissue Fluorescence Spectroscopy Lecture 16

Outline Steady-state fluorescence –Instrumentation and Data Analysis Methods Statistical methods: Principal components analysis Empirical methods: Ratio imaging Modeling: Quantitative extraction of biochemical info –Fluorescence in disease diagnostics –Fluorescence in disease therapeutics

Fluorescence spectra provide a rich source of information on tissue state NADH FAD Collagen Trp Protein expression Structural integrity Metabolic activity Courtesy of Nimmi Ramanujam, University of Wisconsin, Madison

Development of cancer involves a series of changes some of which can be probed by fluorescence protein expression (Trp) metabolic activity (NADH/FAD) nuclear morphology organization structural integrity (collagen) angiogenesis

Instrumentation for clinical tissue fluorescence measurements can be very simple, compact and relatively cheap Courtesy of Urs Utzinger, University of Arizona

Consistent autofluorescence differences have been detected between normal, pre- cancerous and cancerous spectra Non-dysplastic Barrett’s esophagus Low-grade dysplasia High-grade dysplasia Wavelength (nm) Normalized fluorescence intensity Promising studies in GI tract Cervix Lung Oral cavity Breast Artery Bladder

Methods of data analysis Main goal for fluorescence diagnostics: Identify fluorescence features that can be used to identify/classify tissue as normal or diseased. Main approaches –Statistical –Empirical –Model Based

Data analysis: Empirical and statistical algorithms Data pre- processing Normalization Data reduction and Feature extraction Principal Component Analysis Ratio methods Classification

Detection of cervical pre- cancerous lesions using fluorescence spectroscopy: Principal components analysis Rebecca Richards Kortum group UT Austin

Detection of cervical pre-cancerous lesions During the natural lifetime of a woman, squamous epithelium which lines the ectocervix gradually replaces the columnar epithelium of the endocervix, within an area known as the transformation zone. The replacement of columnar epithelium by squamous epithelium is known as squamous metaplasia. Most pre-cancerous lesions of the cervix develop within the transformation zone. The Papanicolaou (Pap) smear is the standard screening test for cervical abnormalities If a Pap smear yields atypical results, the patient undergoes a colposcopy, i.e. magnified (typically 6X to 15X) visualization of the cervix. 3-6% acetic acid is applied to the cervix and abnormal areas are biopsied and evaluated histo 4-6 billion dollars are spent annually in the US alone for colposcopic evaluation and treatment Major disadvantage colposcopic evaluation is its wide range of sensitivity (87-99%) and specificity (23-87%), even in expert hands. endocervix ectocervix Transformation zone Colposcopic view of uterine cervix ectocervix endocervix

Major tissue histopathological classifications Normal squamous epithelium Squamous metaplasia Low-grade squamous intraepithelial lesion High-grade squamous intraepithelial lesion Carcinoma

Instrumentation

PRE-PROCESSING Normalized Spectra at Three Excitation Wavelengths Normalized, Mean-scaled Spectra at Three Excitation Wavelengths DIMENSION REDUCTION: PRINCIPAL COMPONENT ANALYSIS CLASSIFICATION: LOGISTIC DISCRIMINATION Posterior Probability of being NS or SIL Posterior Probability of being LG or HG Posterior Probability of being NC or SIL Posterior Probability of being SIL or NON SIL Posterior Probability of being HG SIL or NON HG SIL DEVELOPMENT OF COMPOSITE ALGORITHMS Constituent Algorithm 1 Constituent Algorithm 3Constituent Algorithm 2 (1,2) (1,2,3) SELECTION OF DIAGNOSTIC PRINCIPAL COMPONENTS: T-TEST Composite Screening Algorithm Composite Diagnostic Algorithm 337 nm Excitation 380 nm Excitation 460 nm Excitation Courtesy of N. Ramanujam; Photochem. Photobiol. 64: , 1996

Data Pre- Processing Step 1 Pre- Processing Step 2 Normal squamous Low-grade High-grade Normal columnar

Principal Component Analysis Spectrum=  w i *B i w=component weight B=component loading describing data variance spectra Component loadings

Dimension reduction: Principal Component Analysis Component loadings spectra 337 nm 380 nm 460 nm

PCA Step 2: Calculate probability of belonging to category based on component weights and classify ▲Low-grade SIL ● High-grade SIL □ Normal squamous ▲Low-grade SIL ● High-grade SIL □ Normal columnar □ Non-dysplastic Barrett’s esophagus X Dysplatic Barrett’s esophagus

Fluorescence spectroscopy is a promising tool for the detection of cervical pre- cancerous lesions

Spectroscopic analysis using PCA Uses full spectrum information to optimize sensitivity and specificity Relatively easy to implement (automated software) Provides no intuition with regards to the origin of spectral differences

Spectroscopic imaging: fluorescence ratio methods for detection of lung neoplasia B. Palcic et al, Chest 99:742-3, 1991

LIFE schematic B. Palcic et al, Chest 99:742-3, 1991

Detection of lung carcinoma in situ using the LIFE imaging system Courtesy of Xillix Technologies ( White light bronchoscopy Autofluorescence ratio image Carcinoma in situ

Autofluorescence enhances ability to localize small neoplastic lesions S Lam et al. Chest 113: , 1998

Test Definitions Has diseaseDoes not have disease Tests positive(A) True positive (B) False positive (A+B) Total # who test positive Tests negative(C) False negative (D) True negative (C+D) Total # who test negative (A+C) Total # who have disease (B+D) Total # who do not have disease Sensitivity=A/(A+C) Specificity=D/(B+D) Positive predictive value=A/(A+B) Negative predictive value=D/(C+D)

Statistical definitions Positive predictive value: probability that patient has the disease when restricted to those patients who test positive Negative predictive value: probability that patient doesn’t have the disease when restricted to those patients who test negative Sensitivity: probability that the test is positive given to a group of patients with the disease Specificity: probability that the test is negative given to a group of patients without the disease

Fluorescence imaging based on ratio methods Wide field of view (probably a huge advantage for most clinical settings) Eliminates effects of distance and angle of illumination Easy to implement Provides no intuition with regards to origins of spectral differences

What are the origins of the observed differences? wavelength (nm) Intrinsic fluorescence 337 nm excitation 358 nm excitation 381 nm excitation 397 nm excitation 412 nm excitation 425 nm excitation Collagen NADH

Collagen and NADH spectra are sufficiently distinct only for some excitation wavelengths 337 nm excitation358 nm excitation

Tissue absorption and scattering may affect significantly tissue fluorescence scattering –elastic scattering multiple scattering absorption –Hemoglobin, beta carotene fluorescence single scattering epithelium Connective tissue

Is hemoglobin absorption a problem? fluorescence wavelength (nm) reflectance 337 nm excitation wavelength (nm) To get answer use Monte Carlo simulations Analytical Modeling